Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07284576
PHASE2

Ultralow Dose PET Imaging of 18F-flurpiridaz

Sponsor: Akiva Mintz

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for known or suspected coronary artery disease (for detecting myocardial ischemia or infarction) detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer called Fluorine-18 (18F)-flurpiridaz and be imaged on a new type of high sensitivity PET scanner for up to 3 hours

Official title: Evaluation of 0.25mCi PET Imaging for Detecting Cardiac Perfusion

Key Details

Gender

All

Age Range

18 Years - 120 Years

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2025-12

Completion Date

2030-06-30

Last Updated

2025-12-16

Healthy Volunteers

Yes

Interventions

DRUG

18F-flurpiridaz

Participants will be injected with 18F-flurpiridaz and imaged for up to 3 hours on a PET scanner

Locations (1)

Nuclear Imaging Institute

Englewood, New Jersey, United States